TRU Diagnostics Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- trudiagnostic.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $74,660 |
| FY2025 | $16,100 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Air Force | $74,660 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Creation of dynamic, non-stochastic, W function informed methylation risk scores (MRS) for diagnostic/therapeutic… | National Institute on Aging (NIH) | $320,511 |
Similar vendors
About the company
TRU Diagnostics Inc., a for-profit corporation based in Lexington, Kentucky, provides epigenetic testing services and DNA methylation risk scoring to federal research and defense agencies as a prime contractor. The vendor operates exclusively as a prime (100% of recent awards) with no subcontract footprint, competing across full-and-open and Total Small Business set-asides without designation under SBA 8(a), HUBZone, SDVOSB, or WOSB programs.
TRU Diagnostics delivers concrete diagnostic and research capabilities in DNA methylation analysis and epigenomic biomarker development. Recent work includes a $74,660 Total Small Business purchase order from the Air Force Research Laboratory (AFRL), awarded July 16, 2026, for DNA methylation risk scores quantifying occupational exposures in military aviation personnel, due for completion October 16, 2026; a $16,100 firm fixed price purchase order from the National Heart, Lung, and Blood Institute (NHLBI) for third-party laboratory services supporting the Division of Intramural Research's Epidemiology and Community Health Branch and Laboratory of Genomic Instability and Cardiopulmonary Outcomes; and a $320,511 Project Grant (CFDA 93.866) from the National Institute on Aging under the Aging Research program, awarded September 20, 2025, for development of novel non-stochastic methylation risk scores using systems-based dynamical modeling to improve diagnostic capabilities for chronic disease management and personalized health forecasting, with completion targeted for September 19, 2026.
Customer concentration is divided equally across three federal agencies: AFRL (1 award, $74,660), NHLBI (1 award, $16,100), and NIA (1 award, value subject to ongoing grant disbursement). Activity remains light — one award per year across 2024, 2025, and 2026 — with one award (the AFRL purchase order) reaching completion inside the next twenty-four months. The vendor carries no active parent contract vehicles, GWACs, or BPAs in the federal award portfolio, and maintains no documented subcontractor relationships.
Quick answers
Is TRU Diagnostics Inc. registered in SAM.gov?
TRU Diagnostics Inc.'s SAM.gov registration expired on August 8, 2026.
What is TRU Diagnostics Inc.'s CAGE code?
TRU Diagnostics Inc.'s CAGE code is 94K27, and its Unique Entity ID (UEI) is DCV4HAV3YQB4.
How much has TRU Diagnostics Inc. received in federal contracts?
Federal contracts obligated $16,100 to TRU Diagnostics Inc. in fiscal year 2025 and $90,760 in fiscal years 2023 through 2027.
What is TRU Diagnostics Inc.'s most recent federal award?
TRU Diagnostics Inc.'s most recent federal contract award is Deoxyribonucleic acid (DNA) methylation risk scores for occupational exposures in military aviation personnel (FA864926P0353), from Air Force Research Laboratory (AFMC), on July 16, 2026.
On GovTribe
See TRU Diagnostics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors